Published in Arthritis Res Ther on September 24, 2009
Dynamic loading enhances integrative meniscal repair in the presence of interleukin-1. Osteoarthritis Cartilage (2010) 0.96
Regional variation in the mechanical role of knee meniscus glycosaminoglycans. J Appl Physiol (1985) (2011) 0.86
IL-10 ameliorates TNF-α induced meniscus degeneration in mature meniscal tissue in vitro. BMC Musculoskelet Disord (2017) 0.75
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci (2002) 4.23
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls. Arthritis Rheum (1998) 3.21
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem (2001) 2.58
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis (2000) 2.32
Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum (1993) 2.10
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett (2000) 2.03
Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem (1991) 2.02
Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem (2003) 1.93
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun (2000) 1.90
Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum (1995) 1.86
Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum (2003) 1.82
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem (1995) 1.70
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum (2001) 1.66
Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol (1996) 1.44
The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res (2001) 1.38
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett (2001) 1.31
The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol (1998) 1.31
Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem (1999) 1.23
Enhanced integrative repair of the porcine meniscus in vitro by inhibition of interleukin-1 or tumor necrosis factor alpha. Arthritis Rheum (2007) 1.21
Regulation of matrix turnover in meniscal explants: role of mechanical stress, interleukin-1, and nitric oxide. J Appl Physiol (1985) (2003) 1.20
The concentration, gene expression, and spatial distribution of aggrecan in canine articular cartilage, meniscus, and anterior and posterior cruciate ligaments: a new molecular distinction between hyaline cartilage and fibrocartilage in the knee joint. Connect Tissue Res (2005) 1.18
Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem (1997) 1.16
Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J Biol Chem (2003) 1.13
Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus. Clin Orthop Relat Res (2008) 1.11
TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett (2003) 1.08
Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro. J Orthop Res (2008) 1.06
Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol (1993) 1.05
Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta (2001) 1.05
Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee. J Orthop Res (2002) 1.03
ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain. J Biol Chem (2002) 1.02
Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum (1999) 1.00
Interleukin-1 and tumor necrosis factor alpha inhibit repair of the porcine meniscus in vitro. Osteoarthritis Cartilage (2007) 0.96
Generation of nitric oxide by lapine meniscal cells and its effect on matrix metabolism: stimulation of collagen production by arginine. J Orthop Res (1998) 0.95
An assay for matrix metalloproteinases and other proteases acting on proteoglycans, casein, or gelatin. Anal Biochem (1993) 0.89
Nitric oxide: an important articular free radical. J Bone Joint Surg Am (1996) 0.88
Chondrocyte apoptosis and regional differential expression of nitric oxide in the medial meniscus following partial meniscectomy. J Orthop Res (2001) 0.88
Aggrecanase. A target for the design of inhibitors of cartilage degradation. Ann N Y Acad Sci (1999) 0.88
Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties. Matrix Biol (2006) 0.86
IL-1 and iNOS gene expression and NO synthesis in the superior region of meniscal explants are dependent on the magnitude of compressive strains. Osteoarthritis Cartilage (2008) 0.84
Meniscal tissue explants response depends on level of dynamic compressive strain. Osteoarthritis Cartilage (2008) 0.84
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity (2004) 3.26
The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol (2004) 2.19
The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res (2010) 1.87
Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up. Knee (2006) 1.83
Production of endogenous antibiotics in articular cartilage. Arthritis Rheum (2004) 1.55
Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol (2007) 1.46
Onset of preclinical osteoarthritis: the angular spatial organization permits early diagnosis. Arthritis Rheum (2011) 1.43
Expression of VEGF and its receptors in different brain tumors. Neurol Res (2005) 1.42
Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum (2004) 1.38
Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. J Biomech (2004) 1.37
Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr Opin Rheumatol (2002) 1.36
Pathomechanisms of cartilage destruction by mechanical injury. Ann Anat (2005) 1.31
Establishment and controlled differentiation of neural crest stem cell lines using conditional transgenesis. Differentiation (2007) 1.30
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J Neurochem (2005) 1.28
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol (2004) 1.25
Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol (2004) 1.18
Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer (2006) 1.14
Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol (2002) 1.09
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res (2010) 1.09
Evaluation of medium supplemented with insulin-transferrin-selenium for culture of primary bovine calf chondrocytes in three-dimensional hydrogel scaffolds. Tissue Eng (2005) 1.08
Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr (2006) 1.06
A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal Biochem (2008) 1.04
An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. Ann Anat (2012) 1.04
Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage. Matrix Biol (2004) 1.03
Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci (2010) 1.02
Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1alpha) in tendon fibroblasts. J Orthop Res (2004) 1.02
The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. Glia (2011) 1.01
Percutaneous aortic valve replacement: endovascular resection of human aortic valves in situ. J Thorac Cardiovasc Surg (2008) 1.00
Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J Leukoc Biol (2002) 0.99
Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum (2011) 0.98
Self-assembling peptide hydrogels modulate in vitro chondrogenesis of bovine bone marrow stromal cells. Tissue Eng Part A (2010) 0.97
Vulnerability of the superficial zone of immature articular cartilage to compressive injury. Arthritis Rheum (2010) 0.97
Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol (2006) 0.96
Influence of 17beta-estradiol and insulin on type II collagen and protein synthesis of articular chondrocytes. Bone (2006) 0.96
The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Mol Cell Neurosci (2008) 0.95
Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis. Arthritis Rheum (2003) 0.94
Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. J Orthop Res (2008) 0.93
MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses. PLoS One (2008) 0.93
Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res (2002) 0.93
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum (2005) 0.92
Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Glia (2008) 0.92
Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology (2005) 0.91
The influence of oxygen and hydrostatic pressure on articular chondrocytes and adherent bone marrow cells in vitro. Biorheology (2004) 0.91
Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther (2006) 0.91
Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage. Cell Tissue Res (2005) 0.90
Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas. J Neurochem (2006) 0.90
Multiple trauma induces serum production of host defence peptides. Injury (2011) 0.90
Iron oxide-loaded liposomes for MR imaging. Front Biosci (2008) 0.89
Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells. J Neuropathol Exp Neurol (2010) 0.89
The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone (2003) 0.89
Pulmonary expression of vascular endothelial growth factor in sepsis. Arch Pathol Lab Med (2003) 0.89
Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. Clin Exp Metastasis (2011) 0.88
Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor. Anat Embryol (Berl) (2002) 0.87
CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol Rep (2012) 0.86
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. Cancer Immunol Immunother (2003) 0.86
Mechanical factors influence the expression of endostatin--an inhibitor of angiogenesis--in tendons. J Orthop Res (2003) 0.86
Spheroid confrontation assay: a simple method to monitor the three-dimensional migration of different cell types in vitro. Ann Anat (2011) 0.85
The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas. Neurochem Int (2012) 0.85
Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. Cell Tissue Res (2010) 0.85
Cannabinoid receptors in human astroglial tumors. J Neurochem (2006) 0.85
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells. Cell Tissue Res (2014) 0.84
Extracellular matrix changes in knee joint cartilage following bone-active drug treatment. Cell Tissue Res (2006) 0.84
The CXCL16-CXCR6 chemokine axis in glial tumors. J Neuroimmunol (2013) 0.84
Expression and regulation of antimicrobial peptides in articular joints. Ann Anat (2005) 0.84
The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system. Ann Anat (2005) 0.83
Tissue engineering of articular cartilage under the influence of collagen I/III membranes and low oxygen tension. Tissue Eng (2004) 0.83
The phytoestrogens daidzein and genistein enhance the insulin-stimulated sulfate uptake in articular chondrocytes. Cell Tissue Res (2008) 0.83
The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing. Arch Orthop Trauma Surg (2003) 0.83
Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16. J Neuroimmunol (2008) 0.83
Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells. J Neurooncol (2003) 0.83
Antimicrobial Peptide immunity protects human nasal and auricular cartilage against infection. J Craniofac Surg (2010) 0.82
Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation. J Invest Dermatol (2006) 0.82
The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. J Pathol (2003) 0.81
CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int J Cancer (2002) 0.81
Differential expression and functionality of TRPA1 protein genetic variants in conditions of thermal stimulation. J Biol Chem (2012) 0.81
Percutaneous aortic valve replacement: gross anatomy and histological findings after transapical and endoluminal resection of human aortic valves in situ. Eur J Cardiothorac Surg (2009) 0.80
Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells. Regul Pept (2002) 0.80
The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas. Oncol Rep (2012) 0.80
Percutaneous aortic valve replacement: computed tomography scan after valved stent implantation in human cadaver hearts. Eur J Cardiothorac Surg (2009) 0.79
The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis. Exp Cell Res (2012) 0.79
The effect of estrogens and dietary calcium deficiency on the extracellular matrix of articular cartilage in Göttingen miniature pigs. Ann Anat (2002) 0.79
VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification. Bone (2004) 0.79
The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytes. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
Stress-vs-time signals allow the prediction of structurally catastrophic events during fracturing of immature cartilage and predetermine the biomechanical, biochemical, and structural impairment. J Struct Biol (2013) 0.78
Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. Invest Ophthalmol Vis Sci (2002) 0.78
Periosteum stimulates subchondral bone densification in autologous chondrocyte transplantation in a sheep model. Cell Tissue Res (2004) 0.78